Pilot Study to Determine Effects of the Btk Inhibitor PCI-32765 on Leukemia Cell Kinetics and Trafficking, Using Heavy Water Labeling in Subjects With CLL and SLL
Clinical trial NCT01752426 · COMPLETED
Trial details
- NCT number
- NCT01752426
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-12-17
- Primary completion
- 2018-08-09
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.